Arkema S.A. (ENXTPA:AKE) agreed to acquire The Dow Chemical Company from Dow Inc. (NYSE:DOW) for an enterprise value of $150 million on May 2, 2024. The project is subject to the approval of certain antitrust authorities and is expected to close in the fourth quarter of 2024.